George Dimitriadis is Professor Emeritus of Pathology and Metabolic Diseases at the National and Kapodistrian University of Athens (NKUA). He graduated from the School of Medicine at NKUA. He earned his first Ph.D. in clinical research (National and Kapodistrian University of Athens) and his second Ph.D. (DPhil) in basic research in metabolism (University of Oxford, United Kingdom). He was a Research Fellow in the “Department of Endocrinology and Diabetes” at the Mayo Clinic (University of Minneapolis, Minnesota, USA) and in the “Department of Biochemistry and Cellular Metabolism” at the University of Oxford, United Kingdom. He was a member of the Executive Committee of the “European Association for the Study of Diabetes (EASD)” (2002–2005) and served as Secretary General of the Organizing Committee for the41st Annual Meeting of the EASD in Athens (2005). Academic/Administrative Positions: (1) 2010–2019 Director of the Second Teaching Department of Internal Medicine, Research Unit, and Diabetes Center of the National and Kapodistrian University of Athens (NKUA) at Attikon University Hospital, (2) 2015–2017 Director of the Department of Internal Medicine at the National and Kapodistrian University of Athens School of Medicine, (3) 2016–2019: Member of the “Committee on Graduate Education and Continuing Education” of KESY, (4) 2017–2020 Deputy Coordinator of the “Diabetes Mellitus Committee” of KESY, (5) 2017–2021 President of the Hellenic Diabetes Association. He is a member of the Editorial Board of the journal *Nutrients* and a reviewer for international medical journals, including *Diabetes Care*, the European Journal of Endocrinology, the European Journal of Nutrition, the Journal of Clinical Endocrinology and Metabolism, the Journal of Clinical Medicine, Metabolism, and Nutrients. His research interests include: (1) the effect of anti-insulin hormones (thyroxine, glucocorticoids, growth hormone) on the sensitivity of the liver, skeletal muscle, and adipose tissue to insulin, (2) the mechanisms of insulin action in physiology and disease, (3) therapeutic management of type 1 diabetes (T1D) and type 2 diabetes (T2D), and (4) the pathophysiology of obesity and T2D. He has over 300 publications in peer-reviewed foreign-language medical journals and books, 15,988 citations in the international literature, and an H-index of 64.
